Similarly, there was a nonsignificant trend toward an increased proportion of patients treated within the 14‐day benchmark, with 64% and 68% of patients who started DMARD treatment after diagnosis meeting this benchmark in 2007 and 2014, respectively.
← all excerpts
High Adherence to System-Level Performance Measures for Rheumatoid Arthritis in a National Early Arthritis Cohort Over Eight Years.
1
—
—